Erratum: A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells

Documenti analoghi

• A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells
  di: Qiu, Lei, et al.
  Pubblicazione: (2015)
• Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy
  di: Qiu, Lei, et al.
  Pubblicazione: (2012)
• Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell
  di: Wang, Qianli, et al.
  Pubblicazione: (2007)
• Synthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine Candidates
  di: Yu, Shichong, et al.
  Pubblicazione: (2011)
• Synthetic and Immunological Studies of 5′-N-phenylacetyl sTn to Develop Carbohydrate-Based Cancer Vaccines and to Explore the Impacts of Linkage between Carbohydrate Antigens and Carrier Proteins
  di: Wang, Qianli, et al.
  Pubblicazione: (2008)